Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics Shareholders Equity (Quarterly) : 29.42M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 29.42M |
| December 31, 2025 | 29.70M |
| September 30, 2025 | 12.51M |
| March 31, 2025 | 26.00M |
| Date | Value |
|---|---|
| December 31, 2024 | 13.75M |
| September 30, 2024 | 17.07M |
| June 30, 2024 | 17.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.81M |
| Total Liabilities (Quarterly) | 5.385M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 14.31 |
| Net Debt Paydown Yield | 0.20% |